FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN)

Back

Abstract Title *

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

https://storage.unitedwebnetwork.com/files/1099/f86e25d1ae6fa423c86b9eadef1e8d8a.pdf

First Name *

Donna

Last Name *

Flesher

Number of Co-Authors

Co-author 1

Millie Shah millie@hibio.com Human Immunology Biosciences, Inc Biomarker and Bioanalytical Sciences South San Francisco United States

Co-author 2

Lisa Kivman lisa@hibio.com Human Immunology Biosciences, Inc, a Biogen company Biomarkers and Bioanalytical Sciences South San Francisco United States

Co-author 3

Tabea Kraft Tabea.Kraeft@morphosys.com Morphosys AG Clinical Biomarkers Planegg Germany

Co-author 4

Julia Rauser Julia.Rauser@morphosys.com MorphoSys AG Clinical Pharmacology Planegg Germany

Co-author 5

Rainer Boxhammer Rainer.Boxhammer@morphosys.com MorphoSys AG Clinical Biomarkers Planegg Germany

Co-author 6

Stefan Hartle stefan.haertle@morphosys.com Morphosys AG Clinical Pharmacology Planegg Germany

Co-author 7

Brian Schwartz brian@hibio.com Human Immunology Biosciences, Inc, a Biogen Company Clinical Development South San Francisco United States

Co-author 8

Paul Manser paul@hibio.com Human Immunology Biosciences, Inc, a Biogen Company Biostatistics South San Francisco United States

Co-author 9

Leslie Chinn leslie@hibio.com Human Immunology Biosciences, Inc, a Biogen Company Clinical Pharmacology South San Francisco United States

Co-author 10

Uptal Patel uptal@hibio.com Human Immunology Biosciences, Inc, a Biogen Company Clinical Development South San Francisco United States

Co-author 11

Donna Flesher donna@hibio.com Human Immunology Biosciences, Inc, a Biogen Company Biomarker and Bioanalytical Sciences South San Francisco United States

Co-author 12

Krzysztof Kiryluk kk473@cumc.columbia.edu Columbia University Division of Nephrology, Department of Medicine New York United States

Co-author 13

Jonathan Barratt Jonathan@jonathan-barratt-consulting.co.uk University of Leicester Mayer IgA Nephropathy Laboratory Leicester United Kingdom

Co-author 14

Co-author 15

Co-author 16